Production —
Training activity: 9

Details

Audit the process for product release and make recommendations for actions

Type

Developmental training activity (DTA)

Evidence requirements

Evidence the activity has been undertaken by the trainee​.

Reflection on the activity at one or more time points after the event including learning from the activity and/or areas of the trainees practice for development.

An action plan to implement learning and/or to address skills or knowledge gaps identified.

Considerations

• Regulatory and good practice guidance
• Current processes and potential impact on patient safety
• Regulatory framework
• Potential impact of OOS or deviation on acceptability and patient safety
• Pharmaceutical quality system
• Documentation
• Training needs
• Physical release process
• Decision making process

Reflective practice guidance

The guidance below is provided to support reflection at different time points, providing you with questions to aid you to reflect for this training activity. They are provided for guidance and should not be considered as a mandatory checklist. Trainees should not be expected to provide answers to each of the guidance questions listed.

Before action

• What criteria will you use to assess the effectiveness of the product release process and to formulate your recommendations for improvement?
• What specific understanding do you hope to gain about the critical checks and decisions involved in the final release of pharmaceutical products to ensure quality and safety?
• How do you expect this activity will enhance your understanding of the responsibilities of the Releasing Officer?
• What insights might you gain into the importance of a thorough product release process in preventing substandard or non-compliant products from reaching patients?
• Discuss with your training officer the department’s product release process, including the roles involved and the documentation reviewed.
• Review the principles of auditing and consider the key elements of an effective product release system.
• Consider the potential risks associated with inadequate product release and how these can be mitigated.

In action

• Pay attention to your actions while auditing the product release process.
  • How are you approaching the audit? Why are you doing it this way?
  • What decisions are you making as you examine the procedures and records for releasing finished products? For example, how are you determining if all quality checks have been adequately performed?
  • What aspects of auditing product release processes feel intuitive, and what requires more conscious effort or reference to relevant quality standards and GMP?
• How effective are your actions in identifying strengths and weaknesses in the product release process?
  • What challenges are you facing as you review documentation and potentially observe the release procedures?
  • What can you learn from the process of conducting this audit as it unfolds? For instance, are you gaining a better understanding of the final checks and balances before a product is made available?
  • How does this activity relate to the role of the Clinical Scientist in production in ensuring patient safety?
• Are there alternative audit techniques you could be considering? For example, are you focusing on batch records or the decision-making process of the Releasing Officer?
  • What support or guidance might you need in the moment if you identify a potential issue that could impact product quality or patient safety?
  • Are you ensuring your recommendations for action are focused on maintaining the quality and safety of the finished pharmaceutical products?

On action

• What were the key steps in the process for releasing finished pharmaceutical products?
  • What criteria and checks were in place for quality assessment before product release?
  • What documentation was reviewed as part of the product release audit?
  • Were there clear roles and responsibilities defined for product release?
  • What strengths and weaknesses did you identify in the product release process?
  • What recommendations did you make for improvement?
• What did you learn about the final checks and balances involved in releasing pharmaceutical products to the market?
  • What are the critical quality attributes that are reviewed before product release?
  • How does the product release process ensure patient safety and efficacy?
  • What are the regulatory requirements related to product release?
• How will you approach auditing product release processes in the future?
  • What key aspects will you focus on to ensure compliance and quality?
  • How will this learning contribute to your overall understanding of pharmaceutical quality management systems?

Beyond action

• Have you reviewed your audit of the product release process and the recommendations you made considering subsequent experiences with quality audits or your understanding of the overall pharmaceutical quality management system?
  • How has your understanding of the responsibilities of the releasing officer evolved since this training activity?
  • Have you participated in or observed other product release processes that have informed your reflections on your audit?
• Has this training activity reinforced your understanding of the critical final step of product release in ensuring patient safety and product quality?
  • How has the experience of auditing a process and making recommendations influenced your ability to critically evaluate other processes and identify areas for improvement?
  • Have you applied your knowledge of GMP and pharmaceutical quality management systems in other aspects of your training?
• How will your experience in auditing product release processes contribute to your future role in quality assurance or regulatory affairs?
  • What skills, such as attention to detail, systematic evaluation, and the ability to communicate audit findings effectively, did you develop through this activity that will be valuable in your future practice?
  • What further learning or experience in advanced auditing techniques, regulatory requirements for product release, and the role of the qualified person would enhance your professional development?

Relevant learning outcomes

#	Outcome
# 1	Outcome Describe the working practices of pharmaceutical production.
# 3	Outcome Perform a range of manufacturing activities, using specialist equipment, in accordance with requirements for GMP and pharmaceutical quality management systems.
# 5	Outcome Perform activities to support safe storage and distribution of medicinal products applying the principles of Good Distribution Practice (GDP).
# 6	Outcome Apply the principles of quality risk management to the manufacturing process.